PGR and breast ductal adenocarcinoma: Most patients were postmenopausal (66.7%), estrogen receptor positive (67.4%), progesterone receptor negative (52.1%), fluorescence in situ hybridization amplified (88.4%), and had ductal carcinoma (87.7%) and Nottingham histological grade ≥2 (85.2%).